Virtual manufacturing system training service launches
Trainees are provided with real-world examples of process workflows.
Zenith Technologies has launched a new virtual customised training service to tackle critical gaps in industry manufacturing software and process training.
The service creates and delivers bespoke, role-based training through state-of-the-art software.
The software replicates each customer’s unique manufacturing environment and provides trainees with real-world examples of process workflows.
David Staunton, director global services at Zenith Technologies, states: “Training services are central to our service offering and help our customers to build capability by addressing skill gaps.”
“A large proportion of current training practises are based on generic content that offers little or no site detail or customisation and this can lead to gaps in knowledge that makes the training a lot less effective.”
After a consultation with the customer to agree the content of the training, Zenith Technologies produces a bespoke training manual and a virtual training environment designed to meet their exact requirements.
Trainees simply download the designed course and run it within a web browser after paying a one-off fee. No expensive licence or complicated installation is required. The course manual is theirs to keep as a continuous supporting document after the initial training session has taken place.
Staunton added: “We have listened to our clients training frustrations and created a solution which provides customised training courses individual to each customers systems and requirements.
“We see this new Customised Training Solution as the beginning of a new era in industry training and hope to incorporate mixed and augmented reality in the future to build capability even faster.”
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.